Review article: Common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 9, 2011, Pages 1047-1062

  Gisbert, J P ^a   Calvet, X ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN;

B LYMPHOCYTE; CANCER GRADING; CLONAL VARIATION; COMORBIDITY; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELICOBACTER PYLORI ASSOCIATED GASTRIC MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; HISTOPATHOLOGY; HUMAN; INFECTION CONTROL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REINFECTION; REVIEW; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; STOMACH LYMPHOMA; STOMACH SURGERY; SYSTEMATIC REVIEW; THERAPEUTIC MISCONCEPTION; TUMOR RECURRENCE; TUMOR REGRESSION;

ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; STOMACH NEOPLASMS;

EID: 80053939987     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04839.x     Document Type: Review

References (152)

1. Ahmad A, Govil Y, Frank BB,. Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 2003; 98: 975-86. (Pubitemid 36733756)
2. Al-Akwaa AM, Siddiqui N, Al-Mofleh IA,. Primary gastric lymphoma. World J Gastroenterol 2004; 10: 5-11. (Pubitemid 38071968)
3. Farinha P, Gascoyne RD,. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005; 128: 1579-605. (Pubitemid 40692554)
4. Isaacson PG,. Update on MALT lymphomas. Best Pract Res Clin Haematol 2005; 18: 57-68. (Pubitemid 40197865)
5. Fischbach W, Chan AO, Wong BC,. Helicobacter pylori and gastric malignancy. Helicobacter 2005; 10 (Suppl. 1): 34-9. (Pubitemid 41395405)
6. Morgner A, Schmelz R, Thiede C, Stolte M, Miehlke S,. Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastroenterol 2007; 13: 3554-66. (Pubitemid 47162262)
7. Zullo A, Hassan C, Cristofari F, Perri F, Morini S,. Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond. World J Gastrointest Oncol 2010; 2: 181-6.
8. Morris GJ, Dotan E, Smith MR, Hagemeister FB Jr, Brereton HD,. Gastric mucosa-associated lymphoid tissue lymphoma. Semin Oncol 2010; 37: 183-7.
9. Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T,. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol 2010; 7: 336-46.
10. Siddiqui ST, Naz E, Danish F, Mirza T, Aziz S, Ali A,. Frequency of Helicobacter pylori in biopsy proven gastritis and its association with lymphoid follicle formation. J Pak Med Assoc 2011; 61: 138-41.
11. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG,. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-6.
12. Genta RM, Graham DY,. Primary gastric MALT lymphoma: trivial condition or serious disease? Helicobacter 1997; 2 (Suppl 1): S56-60.
13. Montalban C, Norman F,. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond. Expert Rev Anticancer Ther 2006; 6: 361-71. (Pubitemid 44192918)
14. Owens SR, Smith LB,. Molecular aspects of H. pylori-related malt lymphoma. Patholog Res Int 2011; 2011: 193149.
15. Genta RM, Hamner HW, Graham DY,. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 1993; 24: 577-83. (Pubitemid 23162223)
16. Isaacson PG, Spencer J,. Is gastric lymphoma an infectious disease? Hum Pathol 1993; 24: 569-70. (Pubitemid 23162221)
17. Gisbert JP, Boixeda D, Alvarez Baleriola I, Manzanal A,. A favorable clinical, endoscopic and histological response after Helicobacter pylori eradication in a patient with a suspected gastric lymphoma. Rev Clin Esp 1995; 195: 886-7.
18. Gisbert JP,. Is gastric lymphoma an infectious disease? Med Clin (Barc) 1998; 110: 56-61.
19. Wotherspoon AC, Dogan A, Du MQ,. Mucosa-associated lymphoid tissue lymphoma. Curr Opin Hematol 2002; 9: 50-5. (Pubitemid 34025312)
20. Yakoob MY, Hussainy AS,. Chronic gastritis and Helicobacter pylori: a histopathological study of gastric mucosal biopsies. J Coll Physicians Surg Pak 2010; 20: 773-5.
21. Musshoff K,. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie 1977; 153: 218-21. (Pubitemid 8097721)
22. Radaszkiewicz T, Dragosics B, Bauer P,. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992; 102: 1628-38.
23. Ruskone-Fourmestraux A, Fischbach W, Aleman BM, et al. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011; 60: 747-58.
24. Kim SS, Ruiz VE, Carroll JD, Moss SF,. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett 2011; 305: 228-38.
25. Thiede C, Morgner A, Alpen B, et al. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology 1997; 113 (6 Suppl.): S61-4.
26. Reason J,. Human error: models and management. BMJ 2000; 320: 768-70. (Pubitemid 30179429)
27. Brennan TA, Gawande A, Thomas E, Studdert D,. Accidental deaths, saved lives, and improved quality. N Engl J Med 2005; 353: 1405-9. (Pubitemid 41362712)
28. Studdert DM, Mello MM, Gawande AA, et al. Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med 2006; 354: 2024-33.
29. Leape LL, Berwick DM,. Safe health care: are we up to it? BMJ 2000; 320: 725-6. (Pubitemid 30179414)
30. Helmreich RL,. On error management: lessons from aviation. BMJ 2000; 320: 781-5. (Pubitemid 30179433)
31. Reason J,. Beyond the organisational accident: the need for 'error wisdom' on the frontline. Qual Saf Health Care 2004; 13 (Suppl. 2): ii28-33. (Pubitemid 39627120)
32. Kohn LT, Corrigan JM, Donaldson MS,. To Err is Human: Building a Safer Health System. Washington, DC: National Academies Press, 1999.
33. Rosin D, Rosenthal RJ, Bonner G, Grove MK, Sesto ME,. Gastric MALT lymphoma in a Helicobacter pylori-negative patient: a case report and review of the literature. J Am Coll Surg 2001; 192: 652-7. (Pubitemid 32422242)
34. Asenjo LM, Gisbert JP,. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig 2007; 99: 398-404.
35. Pervez S, Ali N, Aaqil H, Mumtaz K, Siddiq Ullah S, Akhtar N,. Gastric MALT lymphoma: a rarity. J Coll Physicians Surg Pak 2011; 21: 171-2.
36. Gisbert JP, Aguado B, Luna M, et al. Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases. Rev Esp Enferm Dig 2006; 98: 655-65.et al. (Pubitemid 350259139)
37. Xu W, Zhou C, Zhang G, Wang H, Wang L, Guo J,. Repeating gastric biopsy for accuracy of gastric lymphoma diagnosis. Gastroenterol Nurs 2010; 33: 313-7.
38. Ono S, Kato M, Ono Y, et al. Target biopsy using magnifying endoscopy in clinical management of gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol 2011; 26: 1133-8.
39. Eck M, Schmausser B, Greiner A, Muller-Hermelink HK,. Helicobacter pylori in gastric mucosa-associated lymphoid tissue type lymphoma. Recent Results Cancer Res 2000; 156: 9-18.
40. Chiang IP, Wang HH, Cheng AL, Lin JT, Su IJ,. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: clinicopathologic analysis of 19 cases. J Formos Med Assoc 1996; 95: 857-65.
41. Eck M, Greiner A, Schmausser B, et al. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis. Mod Pathol 1999; 12: 1148-51. (Pubitemid 30033549)
42. Lehours P, Ruskone-Fourmestraux A, Lavergne A, Cantet F, Megraud F,. Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma? Am J Gastroenterol 2003; 98: 291-5. (Pubitemid 36232374)
43. Bouzourene H, Haefliger T, Delacretaz F, Saraga E,. The role of Helicobacter pylori in primary gastric MALT lymphoma. Histopathology 1999; 34: 118-23. (Pubitemid 29083212)
44. Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M,. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997; 79: 3-11. (Pubitemid 26425501)
45. Shinagare AB, Ramaiya NH, O'Regan K, Jagannathan JP, Hornick JL, LaCasce AS,. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2011; 29: e297-300.
46. Chan AO, Chu KM, Yuen ST, Leung SY, Lam SK, Wong J,. Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and West. Am J Gastroenterol 2001; 96: 1922-4.
47. Kelly SM, Geraghty JM, Neale G,. H pylori, gastric carcinoma, and MALT lymphoma. Lancet 1994; 343: 418. (Pubitemid 24049570)
48. Wotherspoon AC, Isaacson PG,. Synchronous adenocarcinoma and low grade B-cell lymphoma of mucosa associated lymphoid tissue (MALT) of the stomach. Histopathology 1995; 27: 325-31.
49. Goteri G, Ranaldi R, Rezai B, Baccarini MG, Bearzi I,. Synchronous mucosa-associated lymphoid tissue lymphoma and adenocarcinoma of the stomach. Am J Surg Pathol 1997; 21: 505-9. (Pubitemid 27213063)
50. Nakamura S, Aoyagi K, Iwanaga S, Yao T, Tsuneyoshi M, Fujishima M,. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients. Cancer 1997; 79: 1077-85. (Pubitemid 27118203)
51. von Herbay A, Schreiter H, Rudi J,. Simultaneous gastric adenocarcinoma and MALT-type lymphoma in Helicobacter pylori infection. Virchows Arch 1995; 427: 445-50. (Pubitemid 26009619)
52. Nishino N, Konno H, Baba S, et al. Synchronous lymphoma and adenocarcinoma occurring as a collision tumor in the stomach: report of a case. Surg Today 1996; 26: 508-12. (Pubitemid 126426348)
53. Hardman WJ 3rd, Gal AA, Pascal RR,. Gastric adenocarcinoma and low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. South Med J 1997; 90: 426-30. (Pubitemid 27176409)
54. Brocheriou I, Nahon S, Coffin B, et al. Association of a low-grade MALT lymphoma and a slightly differentiated adenocarcinoma of the stomach. Ann Pathol 1997; 17: 109-12. (Pubitemid 27247998)
55. Kanamoto K, Aoyagi K, Nakamura S, et al. Simultaneous coexistence of early adenocarcinoma and low-grade MALT lymphoma of the stomach associated with Helicobacter pylori infection: a case report. Gastrointest Endosc 1998; 47: 73-5. (Pubitemid 28065311)
56. Muller S, Seifert E, Stolte M,. Simultaneous MALT-type lymphoma and early adenocarcinoma of the stomach associated with Helicobacter pylori gastritis. Z Gastroenterol 1999; 37: 153-7. (Pubitemid 29104316)
57. Vaiphei K, Chopra R, Singh R, Singh D,. Synchronous adenocarcinoma and MALT lymphoma of stomach. Indian J Gastroenterol 1999; 18: 36-8.
58. Cammarota G, Larocca LM, D'Ugo D, et al. Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? Hepatogastroenterology 2001; 48: 104-6. (Pubitemid 32226080)
59. Sakai T, Ogura Y, Narita J, et al. Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 2003; 6: 191-6. (Pubitemid 37221570)
60. Kaffes A, Hughes L, Hollinshead J, Katelaris P,. Synchronous primary adenocarcinoma, mucosa-associated lymphoid tissue lymphoma and a stromal tumor in a Helicobacter pylori-infected stomach. J Gastroenterol Hepatol 2002; 17: 1033-6.
61. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
62. Nakamura S, Akazawa K, Yao T, Tsuneyoshi M,. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 1995; 76: 1313-24.
63. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81. (Pubitemid 46854190)
64. Chey WD, Wong BC,. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-25. (Pubitemid 47206706)
65. Fujioka T, Yoshiiwa A, Okimoto T, Kodama M, Murakami K,. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. J Gastroenterol 2007; 42 (Suppl. 17): 3-6. (Pubitemid 46140355)
66. Caselli M, Zullo A, Maconi G, et al. 'Cervia II Working Group Report 2006': guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 2007; 39: 782-9. (Pubitemid 47046643)
67. Mones J, Gisbert JP, Borda F, Dominguez-Munoz E,. Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference. Rev Esp Enferm Dig 2005; 97: 348-74. (Pubitemid 40949533)
68. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7. (Pubitemid 23259233)
69. Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut 2002; 50 (Suppl. 3): III19-24. (Pubitemid 34407452)
70. Gisbert JP, Martin-Asenjo L,. Efficacy of Helicobacter pylori erradication treatment in gastric MALT lymphoma: a systematic review. Gastroenterology 2006; 130 (Suppl. 2): T1907.
71. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105-10.
72. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 2007; 56: 1685-7. (Pubitemid 350206294)
73. Zullo A, Hassan C, Andriani A, et al. Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol 2010; 27: 291-5.
74. Ferreri AJ, Montalban C,. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol 2007; 63: 65-71. (Pubitemid 46810277)
75. Ferreri AJ, Freschi M, Dell'Oro S, Viale E, Villa E, Ponzoni M,. Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol 2001; 25: 95-102. (Pubitemid 32001838)
76. Andriani A, Zullo A, Di Raimondo F, et al. Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study. Aliment Pharmacol Ther 2006; 23: 721-6. (Pubitemid 43344590)
77. Hussell T, Isaacson PG, Crabtree JE, Spencer J,. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-4. (Pubitemid 23259232)
78. Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997; 89: 1350-5. (Pubitemid 27418025)
79. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345: 1591-4.
80. Cavanna L, Pagani R, Seghini P, Zangrandi A, Paties C,. High-grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World J Surg Oncol 2008; 6: 35.
81. Boot H, de Jong D, van Heerde P, Taal B,. Role of Helicobacter pylori eradication in high-grade MALT lymphoma. Lancet 1995; 346: 448-9.
82. Ng WW, Lam CP, Chau WK, et al. Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy. Gastrointest Endosc 2000; 51: 93-6.
83. Timm S, Sailer M, Fuchs KH, Greiner A,. First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori. Gastroenterology 2001; 121: 1025-6. (Pubitemid 32959415)
84. Montalban C, Santon A, Boixeda D, Bellas C,. Regression of gastric high-grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut 2001; 49: 584-7. (Pubitemid 32896991)
85. Morgner A, Miehlke S, Fischbach W, et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001; 19: 2041-8. (Pubitemid 32702549)
86. Miki H, Kobayashi S, Harada H, et al. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. J Gastroenterol 2001; 36: 121-4. (Pubitemid 32237081)
87. Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A,. Helicobacter pylori eradication therapy in gastric high-grade non Hodgkin's lymphoma (NHL). Ann Hematol 2001; 80 (Suppl. 3): B106-7.
88. Salam I, Durai D, Murphy JK, Sundaram B,. Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2001; 13: 1375-8. (Pubitemid 33111986)
89. Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 2005; 97: 1345-53. (Pubitemid 41487802)
90. Al Furaikh SS,. Remission of high-grade B-cell lymphoma in a pediatric patient following Helicobacter pylori eradication. Pediatr Int 2011; 53: 105-7.
91. Chen LT, Lin JT, Shyu RY, et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001; 19: 4245-51.
92. Gretschel S, Hunerbein M, Foss HD, Krause M, Schlag PM,. Regression of high-grade gastric B-cell lymphoma after eradication of Helicobacter pylori. Endoscopy 2001; 33: 805-7. (Pubitemid 32834134)
93. Raderer M, Chott A, Drach J, et al. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann Oncol 2002; 13: 1094-8.
94. Lee SY,. Concerns about the predictive factors for tumor regression, definition, and management of nonresponders, and relapse of gastric mucosa-associated lymphoid tissue lymphoma related to Helicobacter pylori. Gut Liver 2009; 3: 235-6.
95. Park HS, Kim YJ, Yang WI, Suh CO, Lee YC,. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol 2010; 16: 2158-62.
96. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999; 131: 88-95. (Pubitemid 29340559)
97. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297-303. (Pubitemid 32269554)
98. Ye H, Liu H, Raderer M, et al. High incidence of t(11;18) (q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 2003; 101: 2547-50. (Pubitemid 36857611)
99. Akamatsu T, Mochizuki T, Okiyama Y, Matsumoto A, Miyabayashi H, Ota H,. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter 2006; 11: 86-95. (Pubitemid 43363307)
100. Nakamura S, Matsumoto T, Ye H, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 2006; 107: 2770-8. (Pubitemid 44937029)
101. Raderer M, Streubel B, Wohrer S, Hafner M, Chott A,. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006; 55: 616-8.
102. Terai S, Iijima K, Kato K, et al. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 2008; 214: 79-87. (Pubitemid 351176319)
103. Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 2009; 20: 1086-93.
104. Nebiki H, Harihara S, Tsukuda H, Inoue T, Arakawa T,. Regression of gastric MALT lymphoma after unsuccessful anti-H. pylori therapy. Am J Gastroenterol 2000; 95: 3684-6.
105. Yoshikane H, Yokoi T, Hidano H, Sakakibara A, Niwa Y, Goto H,. Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection. J Gastroenterol 1997; 32: 812-6. (Pubitemid 27524990)
106. Nakase H, Okazaki K, Ohana M, et al. The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients. Endoscopy 2002; 34: 343-6. (Pubitemid 34279528)
107. Nomura E, Uchimi K, Abue M, et al. Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori. Nippon Shokakibyo Gakkai Zasshi 2010; 107: 1466-73.
108. Morgner A, Lehn N, Andersen LP, et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 2000; 118: 821-8. (Pubitemid 30243744)
109. Yang YY, Lo SS, Li FY, et al. Helicobacter pylori-negative low-grade extranodal B-cell primary gastric mucosa-associated lymphoid tissue lymphoma. J Chin Med Assoc 2007; 70: 121-5. (Pubitemid 46638155)
110. Lahner E, Milione M, Delle Fave G, Annibale BH,. Pylori negative MALT lymphoma patients successfully treated with antibiotics: doubts about their H. pylori negativity. Gut 2006; 55: 1669. (Pubitemid 44629226)
111. Suzuki H, Saito Y, Hibi T,. Helicobacter pylori and gastric mucosa-associated lymphoid tissue (MALT) lymphoma: updated review of clinical outcomes and the molecular pathogenesis. Gut Liver 2009; 3: 81-7.
112. Lee SK, Lee YC, Chung JB, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. World J Gastroenterol 2004; 10: 223-6. (Pubitemid 38195266)
113. Hong SS, Jung HY, Choi KD, et al. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter 2006; 11: 569-73. (Pubitemid 44674142)
114. Isaacson PG,. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999; 10: 637-45. (Pubitemid 29342367)
115. Montalban C, Santon A, Boixeda D, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 2001; 86: 609-17. (Pubitemid 32601104)
116. Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996; 87: 1255-60. (Pubitemid 26056888)
117. Montalban C, Manzanal A, Boixeda D, et al. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol 1997; 8 (Suppl. 2): 37-9.
118. Thiede C, Alpen B, Morgner A, et al. Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 1998; 16: 3822-31. (Pubitemid 29001535)
119. Isaacson PG, Diss TC, Wotherspoon AC, Barbazza R, De Boni M, Doglioni C,. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology 1999; 117: 750-1. (Pubitemid 29409269)
120. Thiede C, Wundisch T, Alpen B, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001; 19: 1600-9. (Pubitemid 32230859)
121. Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002; 99: 2541-4. (Pubitemid 34525443)
122. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M,. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53: 34-7. (Pubitemid 38083007)
123. Wundisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018-24. (Pubitemid 46657403)
124. Montalban C, Santon A, Redondo C, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 2005; 16: 1539-44. (Pubitemid 41222428)
125. Santon A, Garcia-Cosio M, Bellosillo B, et al. Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18) (q21;q21). Leuk Lymphoma 2008; 49: 1516-22.
126. Aiello A, Giardini R, Tondini C, et al. PCR-based clonality analysis: a reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas? Histopathology 1999; 34: 326-30. (Pubitemid 29229987)
127. Salar A, Bellosillo B, Serrano S, Besses C,. Persistent residual disease in t(11;18) (q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. J Clin Oncol 2005; 23: 7361-2. (Pubitemid 46202349)
128. Rudolph B, Bayerdorffer E, Ritter M, et al. Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma? J Clin Oncol 1997; 15: 1104-9. (Pubitemid 27106295)
129. Doglioni C, Ponzoni M, Ferreri AJ, Savio A,. Gastric lymphoma: the histology report. Dig Liver Dis 2011; 43 (Suppl. 4): S310-8.
130. Nobre-Leitao C, Lage P, Cravo M, et al. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Am J Gastroenterol 1998; 93: 732-6. (Pubitemid 29063912)
131. Savio A, Zamboni G, Capelli P, et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res 2000; 156: 116-24.
132. Montalban C, Manzanal A, Boixeda D, et al. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response. Med Clin (Barc) 1998; 110: 41-4. (Pubitemid 128527835)
133. Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008; 44: 2470-6.
134. Morgner A, Miehlke S, Stolte M, et al. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol 2001; 7: 248-53. (Pubitemid 32377479)
135. Ghoshal UC, Guha D, Bandyopadhyay S, et al. Gastric adenocarcinoma in a patient re-infected with H. pylori after regression of MALT lymphoma with successful anti-H. pylori therapy and gastric resection: a case report. BMC Gastroenterol 2002; 2: 6.
136. Montalban C, Castrillo JM, Lopez-Abente G, et al. Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma 1999; 2: 161-8. (Pubitemid 29116407)
137. Au WY, Gascoyne RD, Le N, et al. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol 1999; 10: 317-21. (Pubitemid 29217223)
138. Herrera-Goepfert R, Arista-Nasr J, Alba-Campomanes A,. Pathologic features of the gastric mucosa adjacent to primary MALT-lymphomas. J Clin Gastroenterol 1999; 29: 266-9. (Pubitemid 29451349)
139. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
140. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94. (Pubitemid 38082812)
141. Horstmann M, Erttmann R, Winkler K,. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment. Lancet 1994; 343: 1098-9. (Pubitemid 24128217)
142. Andriani A, Miedico A, Tedeschi L, et al. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis 2009; 41: 467-73.
143. Kim JS, Chung SJ, Choi YS, et al. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer 2007; 96: 1324-8. (Pubitemid 46685779)
144. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-94. (Pubitemid 34465171)
145. Nakamura S, Matsumoto T, Suekane H, et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 2005; 104: 532-40. (Pubitemid 41022810)
146. Kato H, Kagami Y, Kodaira T, et al. Nodal relapse after Helicobacter
147. Gisbert JP,. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005; 100: 2083-99.
148. Gisbert JP, Luna M, Gomez B, et al. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther 2006; 23: 713-9. (Pubitemid 43344589)
149. Zullo A, Hassan C, Andriani A, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol 2009; 104: 1932-7.
150. Coyle WJ,. Clinical Trial Report: eradication of Helicobacter pylori and MALT lymphoma: where do we stand? Curr Gastroenterol Rep 2010; 12: 229-30.
151. Choi JY, Lee GH, Ahn JY, et al. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I (E1) gastric MALT lymphoma. Helicobacter 2011; 16: 36-41.
152. Wundisch T, Mosch C, Neubauer A, Stolte M,. Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: results of a 196-patient series. Leuk Lymphoma 2006; 47: 2110-4. (Pubitemid 44650087)